Kyowa Kirin (Japan)
In research, Kyowa Kirin (Japan) stands highest in Life Sciences (#2,037 of 14,347 worldwide), Biochemistry, Genetics and Molecular Biology (#1,420 of 7,814 worldwide) and Medicine (#4,692 of 17,978 worldwide), over all time.
- World rank, 2022–2025
- #14,799 of 28,054 · #4,991 all time
- Rank in Japan
- #392 of 1,070
- Research works
- 2.5k ◆ 1% vs 2013–17
- Citations
- 78k 31.5 per fractional work
- Top-10% rate
- 12.1% record average 16.5%
- Open access
- 40% world 28%
What is Kyowa Kirin (Japan) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #2,037 of 14,347 | 13.2% | 1,317 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,420 of 7,814 | 12.8% | 940 | |
| MedicineField | #4,692 of 17,978 | 16.2% | 678 | |
| Health SciencesDomain | #6,272 of 20,462 | 15.6% | 727 | |
| Molecular BiologySubfield | #1,806 of 4,961 | 12.4% | 639 | |
| Physical SciencesDomain | #10,305 of 21,541 | 7.8% | 420 | |
| ChemistryField | #2,567 of 3,369 | 6.9% | 253 | |
| Organic ChemistrySubfield | #1,562 of 2,025 | 7.0% | 219 |
Each strip is that field’s whole ranked pool, with the notch where Kyowa Kirin (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.2×. Every wedge is a field page.
- Immunology and Microbiology 8.2×
- Pharmacology, Toxicology and Pharmaceutics 5.2×
- Biochemistry, Genetics and Molecular Biology 5.0×
- Nursing 3.9×
- Mathematics 2.9×
- Medicine 2.0×
- Neuroscience 1.8×
- Chemistry 1.5×
- Decision Sciences 1.5×
- Materials Science 0.7×
- Veterinary 0.7×
- Economics, Econometrics and Finance 0.4×
- Engineering 0.4×
- Chemical Engineering 0.2×
- Health Professions 0.2×
- Agricultural and Biological Sciences 0.2×
- Computer Science 0.1×
- Earth and Planetary Sciences 0.1×
- Environmental Science 0.1×
- Psychology 0.1×
- Dentistry 0.1×
- Physics and Astronomy 0.0×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
Who are the top researchers at Kyowa Kirin (Japan)?
Ranked on the composite score, Nobuo Hanai, Mitsuo Satoh and Kazuma Tomizuka lead among researchers whose main affiliation is Kyowa Kirin (Japan).
- 1 Nobuo Hanai Japan · #82,991 worldwide 318 citations · 29 works
- 2 Mitsuo Satoh Japan · #186,806 worldwide 202 citations · 20 works
- 3 Kazuma Tomizuka Japan · #187,807 worldwide 256 citations · 20 works
- 4 Kentaro Tamaki Japan · #252,621 worldwide 134 citations · 18 works
- 5 Hiroshi Kase Japan · #336,089 worldwide 130 citations · 21 works
- 6 Tatsuya Tamaoki Japan · #367,708 worldwide 110 citations · 17 works
- 7 Mayumi Yoshida Japan · #371,166 worldwide 131 citations · 35 works
- 8 Shiro Akinaga Japan · #381,135 worldwide 100 citations · 17 works
- 9 Masato Ikeda Japan · #395,757 worldwide 137 citations · 36 works
- 10 Seiji Sugimoto Japan · #396,816 worldwide 43 citations · 19 works
Which keywords describe research at Kyowa Kirin (Japan)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Glycosylation, Inflammation, Therapeutic Antibodies, Chronic Kidney Disease, Therapeutic Targets, Cancer Immunotherapy and Oxidative Stress.
- Tumor Antigen
- Recombinant Proteins
- Leukemia
- Chromatography
- Dendritic Cells
- Immunity
- Adaptive Designs
- Immune System
- phosphate
- Tumor Microenvironment
- Parathyroid Hormone
- Parkinson's Disease
- Biopharmaceuticals
- Lymphoma
- Fc Receptors
- Antibody Engineering
- Therapeutic Targets
- Cancer
- Therapeutic Antibodies
- Monoclonal Antibodies
- Inflammation
- Glycosylation
- Oxidative Stress
- Chronic Kidney Disease
- Cancer Immunotherapy
- Biomarkers
- Innate Immunity
- Stability
- Immunogenicity
- Neurodegeneration
- Prognostic Factors
- FGF23
- Bayesian Methods
- Mitochondrial Dysfunction
- False Discovery Rate
- Neuroprotection
- Gene Therapy
- Diagnostic Criteria
- Protein Aggregation
- Antigen Presentation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation8▲ 3.9×34 topics
- Monoclonal Antibodies6▲ 72×3 topics
- Glycosylation6▲ 53×3 topics
- Therapeutic Antibodies5▲ 80×2 topics
- Oxidative Stress5▲ 3.2×23 topics
- Cancer4▲ 3.2×17 topics
- Chronic Kidney Disease4▲ 17×6 topics
- Therapeutic Targets4▲ 27×6 topics
- Cancer Immunotherapy4▲ 24×2 topics
- Antibody Engineering3▲ 62×1 topic
- Biomarkers3▲ 4.9×8 topics
- Fc Receptors3▲ 62×1 topic
- Innate Immunity3▲ 10×5 topics
- Lymphoma3▲ 21×4 topics
- Stability3▲ 14×2 topics
- Biopharmaceuticals3▲ 61×3 topics
- Immunogenicity3▲ 71×2 topics
- Parkinson's Disease3▲ 13×5 topics
- Neurodegeneration3▲ 10×3 topics
- Parathyroid Hormone3▲ 32×2 topics
- Prognostic Factors3▲ 6.5×4 topics
- Tumor Microenvironment3▲ 6.5×4 topics
- FGF233▲ 83×1 topic
- phosphate3▲ 83×1 topic
- Bayesian Methods2▲ 52×2 topics
- Immune System2▲ 11×4 topics
- Mitochondrial Dysfunction2▲ 8.8×4 topics
- Adaptive Designs2▲ 120×1 topic
- False Discovery Rate2▲ 120×1 topic
- Immunity2▲ 6.0×3 topics
- Neuroprotection2▲ 6.9×4 topics
- Dendritic Cells2▲ 26×2 topics
- Gene Therapy2▲ 12×2 topics
- Chromatography2▲ 148×1 topic
- Diagnostic Criteria2▲ 10×3 topics
- Leukemia2▲ 27×2 topics
- Protein Aggregation2▲ 42×1 topic
- Recombinant Proteins2▲ 73×2 topics
- Antigen Presentation2▲ 25×1 topic
- Tumor Antigen2▲ 35×1 topic
Which research topics does Kyowa Kirin (Japan) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Parathyroid Disorders and Treatments, Statistical Methods in Clinical Trials and Protein purification and stability.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 2 Parathyroid Disorders and Treatments Nephrology 3 works
- 3 Statistical Methods in Clinical Trials Statistics and Probability 2 works
- 4 Protein purification and stability Molecular Biology 2 works
- 5 Immunotherapy and Immune Responses Immunology 2 works
- 6 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
- 7 Cutaneous lymphoproliferative disorders research Dermatology 2 works
- 8 RNA Interference and Gene Delivery Molecular Biology 2 works
- 9 Adenosine and Purinergic Signaling Physiology 2 works
- 10 CAR-T cell therapy research Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Kyowa Kirin (Japan)'s research output changed?
Output in 2018–2022 was 1% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.